You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
江中藥業(600750.SH):擬購買江中昌潤、江中本草100%股權
格隆匯 11-24 18:13

格隆匯11月24日丨江中藥業(600750.SH)公佈,擬以1,347.69萬元購買江西江中醫藥投資發展有限公司(簡稱“江中醫投”)所持有的江西江中昌潤醫藥有限責任公司(簡稱“江中昌潤”)100%股權及江西江中本草健康科技有限公司(簡稱“江中本草”)100%股權,其中:以593.68萬元的交易價款購買江中昌潤100%股權,以754.01萬元的交易價款購買江中本草100%股權,資金來源為公司自有資金。

本次交易完成後,江中昌潤和江中本草將納入公司合併報表範圍。由於本次交易涉及集團公司內同一控制下的企業合併,公司需對2022年度及2023年三季度財務報表進行追溯調整,2022年度營業收入預計增加7,373萬元,歸母淨利潤預計增加297萬元;2023年三季度營業收入預計增加9,658萬元,歸母淨利潤預計增加214萬元。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account